{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:23:36Z","timestamp":1790436216186,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ygyno.2016.11.042","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T21:00:47Z","timestamp":1480971647000},"page":"329-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma"],"prefix":"10.1016","volume":"144","author":[{"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Yunokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin A.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0950-1755","authenticated-orcid":false,"given":"Tadao","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Shida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1633-5385","authenticated-orcid":false,"given":"Yuji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sosuke","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuhei","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munetaka","family":"Takekuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4922-784X","authenticated-orcid":false,"given":"Shiori","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merieme M.","family":"Klobocista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian S.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito M.","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7640-6432","authenticated-orcid":false,"given":"Tadayoshi","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Pejovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian MK","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight D.","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Omatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R.","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.11.042_bb0005","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/IGC.0b013e318244cedc","article-title":"Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989\u20132008","volume":"22","author":"Boll","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2016.11.042_bb0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2015.03.041","article-title":"Uterine carcinosarcoma: a review of the literature","volume":"137","author":"Cantrell","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2214\/AJR.11.7287","article-title":"Uterine sarcomas: then and now","volume":"199","author":"Shah","year":"2012","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0020","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","article-title":"Selective estrogen-receptor modulators \u2014 mechanisms of action and application to clinical practice","volume":"348","author":"Riggs","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0025","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10years versus stopping at 5years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2016.11.042_bb0035","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2002.20.11.2758","article-title":"Association of tamoxifen and uterine sarcoma","volume":"20","author":"Wickerham","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0040","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","article-title":"Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14","volume":"86","author":"Fisher","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0050","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","article-title":"Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of liver and endometrial cancer risk following tamoxifen","volume":"356","author":"Bergman","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2016.11.042_bb0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/jnci\/dji057","article-title":"Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study","volume":"97","author":"Swerdlow","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0060","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/IGC.0b013e31823c3219","article-title":"Prognostic impact of the history of breast cancer and of hormone therapy in uterine carcinosarcoma","volume":"22","author":"Uehara","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2016.11.042_bb0065","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1525-1438.2000.010004280.x","article-title":"Uterine carcinosarcomas in patients receiving tamoxifen. A report of 19 cases","volume":"10","author":"McCluggage","year":"2000","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2016.11.042_bb0070","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1525-1438.2002.01134.x","article-title":"Tamoxifen-related uterine carcinosarcomas occur under\/after prolonged treatment: report of five cases and review of the literature","volume":"12","author":"Kloos","year":"2002","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2016.11.042_bb0075","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1525-1438.1995.05040310.x","article-title":"Is there an association between long-term tamoxifen treatment and the development of carcinosarcoma (malignant mixed Mullerian tumor) of the uterus?","volume":"5","author":"Evans","year":"1995","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2016.11.042_bb0080","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/annonc\/mdw161","article-title":"Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma","volume":"27","author":"Matsuo","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0090","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.ejso.2014.05.007","article-title":"Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363 patients","volume":"40","author":"Ngo","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0095","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygyno.2012.07.105","article-title":"Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure","volume":"127","author":"Tergas","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0100","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(12)60442-5","article-title":"Contemporary management of endometrial cancer","volume":"379","author":"Wright","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2016.11.042_bb0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.AOG.0000131620.67911.03","article-title":"Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?","volume":"104","author":"Slomovitz","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ygyno.2015.08.014","article-title":"Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis","volume":"139","author":"Rauh-Hain","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0115","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1210\/endo.141.9.7649","article-title":"Activation of a uterine insulin-like growth factor I signaling pathway by clinical and environmental estrogens: requirement of estrogen receptor-alpha","volume":"141","author":"Klotz","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2016.11.042_bb0120","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0378-5122(02)00016-6","article-title":"IGF-1 in gynaecology and obstetrics: update 2002","volume":"41","author":"Druckmann","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.ygyno.2016.11.042_bb0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.humpath.2012.05.005","article-title":"PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma","volume":"44","author":"Abe","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.042_bb0130","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/bjc.2013.455","article-title":"Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas","volume":"109","author":"Akiyama-Abe","year":"2013","journal-title":"Br. J. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816316110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816316110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T01:52:23Z","timestamp":1536198743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816316110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0090825816316110"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.11.042","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.11.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}